Percutaneous radiofrequency ablation in the treatment of pulmonary malignancies: efficacy, safety and predictive factors
Metrics: PDF 484 views | HTML 761 views | ?
Tina Streitparth1, Denis Schumacher2, Robert Damm3, Bjoern Friebe3, Konrad Mohnike4, Ortrud Kosiek3, Maciej Pech3, Jens Ricke1 and Florian Streitparth1
1Department of Radiology, University Hospital Munich, Munich, Germany
2Department of Neurology, Clinic of Magdeburg, Magdeburg, Germany
3Department of Radiology, Otto-von-Guericke University Clinic Magdeburg, Magdeburg, Germany
4DTZ, Berlin, Germany
Tina Streitparth, email: email@example.com
Keywords: lung malignancies; radiofrequency ablation; colorectal cancer; microwave ablation
Received: May 05, 2017 Accepted: November 11, 2017 Published: January 18, 2018
Purpose: The purpose of this study was to evaluate the efficacy, safety and predictive factors of RFA of primary and secondary lung malignancies.
Patients and Methods: 79 patients with 129 primary and secondary lung malignancies were enrolled in a retrospective study. We treated 74 pulmonary metastases of colorectal cancer, 13 malignant melanoma lesions, 13 renal cancer metastases, 5 primary lung malignancies and 24 tumors of other different entities. All patients were considered to be unsuitable candidates for surgery, radiotherapy or chemotherapy. The primary endpoint was local tumor control, secondary endpoints were overall survival, safety and predictive factors, e.g. distance to pleura, vessels and bronchi.
Results: The median tumor size was 1.2 cm (0.5–3.0 cm). After a median follow-up of 14 months (3–81 months), the LTC was 85.3 %. There were 34 lesions (26.4%) with complete remission, 48 (37.2 %) partial remission, 28 (21.7%) stable disease and 19 lesions (14.7%) with progressive disease. We evaluated an OS of 27 months. Pneumothorax in 19 cases (14.7%) and pleural effusion in 2 cases (1.6 %) were the leading complications (CTCAE, 5 grade III adverse events). The only significant influence regarding the outcome after RFA was the initial tumor size (p = 0.01). Distance to vessel, bronchi, and pleura showed no significant effect (p = 0.81; p = 0.82; p = 0.80).
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.